From: Genetic polymorphism of the OPG gene associated with breast cancer
SNP | Alleles | Genotypes | |||
---|---|---|---|---|---|
OPG rs2073618 | G | C | GG | CG | CC |
 Invasive tumors | 316 (57.5%) | 234 (42.5%) | 86 (31.3%) | 144 (52.4%) | 45 (16.4%) |
 Non-invasive tumors | 22 (39.3%) | 34 (60.7%) | 6 (21.4%) | 10 (35.7%) | 12 (42.9%) |
 OR (95%CI) p-value* | 2.088 (1.189-3.663) p=0.011 | p=0.006 | |||
RANK rs35211496 | T | C | TT | TC | CC |
 right breasta | 62 (25.2%) | 184 (74.8%) | 9 (7.3%) | 44 (35.8%) | 70 (56.9) |
 left breasta | 53 (15.3%) | 293 (84.7%) | 3 (1.7%) | 47 (27.2%) | 123 (71.1%) |
 OR (95%CI) p-value* | 1.863 (1.236-2.808) p=0.003 | p=0.009 | |||
RANKL rs9533156 | C | T | CC | CT | TT |
 BMI >/=28 | 70 (50.7%) | 68 (49.3%) | 22 (31.9%) | 26 (37.7%) | 21 (30.4%) |
 BMI <28 | 120 (40%) | 180 (60%) | 24 (16.0%) | 72 (48.0%) | 54 (36.0%) |
 OR (95%CI) p-value* | 1.543 (1.029-2.315) p=0.038 | p=0.032 | |||
RANKL rs1054016 | T | G | TT | TG | GG |
 BMI >/=28 | 66 (47.8%) | 72 (52.2%) | 20 (29.0%) | 26 (37.7%) | 23 (33.3%) |
 BMI <28 | 108 (36.0%) | 192 (64.0%) | 19 (12.7%) | 70 (46.7%) | 61 (40.7%) |
 OR (95%CI) p-value* | 1.630 (1.083-2.453) p=0.021 | p=0.018 |